Home » Topics » BioWorld Science

BioWorld Science
RSS

Anticoagulant hirudin analogue NF-22 designated developmental candidate

Aug. 16, 1996

Corvas discloses thrombin inhibitors

Aug. 16, 1996

Favorable safety review for Neuprex

Aug. 16, 1996

Pilot study results reported for CytoTAb

Aug. 16, 1996

PLC Systems granted patent integral to Heart Laser technology

Aug. 16, 1996

Cardiac tropinin provides accurate detection of MI

Aug. 16, 1996

Zynaxis to develop Zyn-Linker form of heparin under SBIR grant

Aug. 16, 1996

Kanebo reports Na+/H+ exchange inhibitors

Aug. 16, 1996

Antihypertensive quinazoline derivatives described by Nippon Chemiphar

Aug. 16, 1996

American Cyanamid claims vasopressin antagonists

Aug. 16, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...